Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation

Experimental Cell Research

Volumn 314, Issue 20, 2008, Pages 3701-3711

  Lemiere, Sylvie ^a,b   Azar, Rania ^a   Belloc, Francis ^c   Gürsel, Demir ^a,b   Pyronnet, Stéphane ^a   Bikfalvi, Andreas ^a,b   Auguste, Patrick ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Fibroblast growth factors; Glioma; Invasion

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HYDROXYUREA; INITIATION FACTOR 4E BINDING PROTEIN 1;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; GENE OVEREXPRESSION; GLIOMA; GLIOMA CELL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA TRANSLATION; TUMOR GROWTH;

RATTUS;

EID: 56249101722     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.09.022     Document Type: Article

References (45)

1. Eswarakumar V.P., Lax I., and Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16 (2005) 139-149
2. Javerzat S., Auguste P., and Bikfalvi A. The role of fibroblast growth factors in vascular development. Trends Mol. Med. 8 (2002) 483-489
3. Bikfalvi A., Klein S., Pintucci G., and Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18 (1997) 26-45
4. Florkiewicz R.Z., Anchin J., and Baird A. The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase. J. Biol. Chem. 273 (1998) 544-551
5. Bossard C., Laurell H., Van den Berghe L., Meunier S., Zanibellato C., and Prats H. Translokin is an intracellular mediator of FGF-2 trafficking. Nat. Cell Biol. 5 (2003) 433-439
6. Maher P.A. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 134 (1996) 529-536
7. Florkiewicz R.Z., Baird A., and Gonzalez A.M. Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors 4 (1991) 265-275
8. Arnaud E., Touriol C., Boutonnet C., Gensac M.C., Vagner S., Prats H., and Prats A.C. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol. Cell. Biol. 19 (1999) 505-514
9. Powell P.P., and Klagsbrun M. Regulation of basic fibroblast growth factor mRNA expression in rat C6 glioma cells. Exp. Cell Res. 209 (1993) 224-230
10. Vagner S., Gensac M.C., Maret A., Bayard F., Amalric F., Prats H., and Prats A.C. Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol. Cell. Biol. 15 (1995) 35-44
11. Vagner S., Touriol C., Galy B., Audigier S., Gensac M.C., Amalric F., Bayard F., Prats H., and Prats A.C. Translation of CUG-but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells. J. Cell Biol. 135 (1996) 1391-1402
12. Galy B., Creancier L., Prado-Lourenco L., Prats A.C., and Prats H. p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA. Oncogene 20 (2001) 4613-4620
13. Grothe C., Meisinger C., Holzschuh J., Wewetzer K., and Cattini P. Over-expression of the 18 kD and 21/23 kD fibroblast growth factor-2 isoforms in PC12 cells and Schwann cells results in altered cell morphology and growth. Brain Res. Mol. Brain Res. 57 (1998) 97-105
14. Bikfalvi A., Klein S., Pintucci G., Quarto N., Mignatti P., and Rifkin D.B. Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms. J. Cell Biol. 129 (1995) 233-243
15. Quarto N., Talarico D., Florkiewicz R., and Rifkin D.B. Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells. Cell Regul. 2 (1991) 699-708
16. Quarto N., Fong K.D., and Longaker M.T. Gene profiling of cells expressing different FGF-2 forms. Gene 356 (2005) 49-68
17. Delrieu I., Faye J.C., Bayard F., and Maret A. Inhibition of interleukin-6 promoter activity by the 24 kDa isoform of fibroblast growth factor-2 in HeLa cells. Biochem. J. 340 Pt 1 (1999) 201-206
18. Delrieu I., Arnaud E., Ferjoux G., Bayard F., and Faye J.C. Overexpression of the FGF-2 24-kDa isoform up-regulates IL-6 transcription in NIH-3T3 cells. FEBS Lett. 436 (1998) 17-22
19. Couderc B., Prats H., Bayard F., and Amalric F. Potential oncogenic effects of basic fibroblast growth factor requires cooperation between CUG and AUG-initiated forms. Cell Regul. 2 (1991) 709-718
20. Maret A., Galy B., Arnaud E., Bayard F., and Prats H. Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line. Cancer Res. 55 (1995) 5075-5079
21. Estival A., Louvel D., Couderc B., Prats H., Hollande E., Vaysse N., and Clemente F. Morphological and biological modifications induced in a rat pancreatic acinar cancer cell line (AR4-2J) by unscheduled expression of basic fibroblast growth factors. Cancer Res. 53 (1993) 1182-1187
22. Auguste P., Gursel D.B., Lemiere S., Reimers D., Cuevas P., Carceller F., Di Santo J.P., and Bikfalvi A. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Cancer Res. 61 (2001) 1717-1726
23. Murphy P.R., Sato Y., and Knee R.S. Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Mol. Endocrinol. 6 (1992) 877-884
24. Joy A., Moffett J., Neary K., Mordechai E., Stachowiak E.K., Coons S., Rankin-Shapiro J., Florkiewicz R.Z., and Stachowiak M.K. Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells. Oncogene 14 (1997) 171-183
25. Ader I., Muller C., Bonnet J., Favre G., Cohen-Jonathan E., Salles B., and Toulas C. The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunit. Oncogene 21 (2002) 6471-6479
26. Gaubert F., Escaffit F., Bertrand C., Korc M., Pradayrol L., Clemente F., and Estival A. Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C delta and epsilon and ERK activation. J. Biol. Chem. 276 (2001) 1545-1554
27. Shockett P., Difilippantonio M., Hellman N., and Schatz D.G. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 6522-6526
28. Colucci F., Soudais C., Rosmaraki E., Vanes L., Tybulewicz V.L., and Di Santo J.P. Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J. Immunol. 162 (1999) 2761-2765
29. Miraux S., Lemiere S., Pineau R., Pluderi M., Canioni P., Franconi J.M., Thiaudiere E., Bello L., Bikfalvi A., and Auguste P. Inhibition of FGF receptor activity in glioma implanted into the mouse brain using the tetracyclin-regulated expression system. Angiogenesis 7 (2004) 105-113
30. Heesom K.J., Gampel A., Mellor H., and Denton R.M. Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1). Curr. Biol. 11 (2001) 1374-1379
31. Mamane Y., Petroulakis E., Rong L., Yoshida K., Ler L.W., and Sonenberg N. eIF4E-from translation to transformation. Oncogene 23 (2004) 3172-3179
32. Pyronnet S., and Sonenberg N. Cell-cycle-dependent translational control. Curr. Opin. Genet. Dev. 11 (2001) 13-18
33. Bonneau A.M., and Sonenberg N. Involvement of the 24-kDa cap-binding protein in regulation of protein synthesis in mitosis. J. Biol. Chem. 262 (1987) 11134-11139
34. Pyronnet S., Dostie J., and Sonenberg N. Suppression of cap-dependent translation in mitosis. Genes Dev. 15 (2001) 2083-2093
35. Cormier P., Pyronnet S., Salaun P., Mulner-Lorillon O., and Sonenberg N. Cap-dependent translation and control of the cell cycle. Prog. Cell Cycle Res. 5 (2003) 469-475
36. Pyronnet S., Pradayrol L., and Sonenberg N. A cell cycle-dependent internal ribosome entry site. Mol. Cell 5 (2000) 607-616
37. Cornelis S., Bruynooghe Y., Denecker G., Van Huffel S., Tinton S., and Beyaert R. Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol. Cell 5 (2000) 597-605
38. Hermanson O., Jepsen K., and Rosenfeld M.G. N-CoR controls differentiation of neural stem cells into astrocytes. Nature 419 (2002) 934-939
39. de Alvaro C., Martinez N., Rojas J.M., and Lorenzo M. Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2. Mol. Biol. Cell 16 (2005) 4454-4461
40. Claus P., Doring F., Gringel S., et al. Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J. Biol. Chem. 278 (2003) 479-485
41. Claus P., Bruns A.F., and Grothe C. Fibroblast growth factor-2(23) binds directly to the survival of motoneuron protein and is associated with small nuclear RNAs. Biochem. J. 384 (2004) 559-565
42. Van den B.L., Laurell H., Huez I., et al. FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2. Mol. Endocrinol. 14 (2000) 1709-1724
43. Shen B., Arese M., Gualandris A., and Rifkin D.B. Intracellular association of FGF-2 with the ribosomal protein L6/TAXREB107. Biochem. Biophys. Res. Commun. 252 (1998) 524-528
44. Gringel S., van Bergeijk J., Haastert K., Grothe C., and Claus P. Nuclear fibroblast growth factor-2 interacts specifically with splicing factor SF3a66. Biol. Chem. 385 (2004) 1203-1208
45. Baguma-Nibasheka M., Li A.W., and Murphy P.R. The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cells. Mol. Cell. Endocrinol. 267 (2007) 127-136